This ann reminded me of the day FDA asked a few questions pre- advisory meeting and the SP knocked back ~40% then about a week SI released ann told us to calm down we prepared well and after that meeting night the SP bounced back, basically they said nothing, we just did our work, the product works
Ann: Remestemcel-L for COPD Published in Respiratory Research, page-66
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.14 |
Change
0.030(2.71%) |
Mkt cap ! $1.290B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.14 | $1.09 | $2.584M | 2.315M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 94558 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.14 | 44319 | 5 |
View Market Depth
| Last trade - 11.01am 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |